Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 14th February 2022 Vol. No. 11; Issue No. 513

1. Shejul J, Chopra S, Ranjan N, Mahantshetty U, Mehta S, Patil P, Engineer R, Gurram L, Phurailatpam R, Swamidas J, Gupta S, Shrivastava S.(2022) Temporal course of late rectal toxicity & impact of intervention in patients undergoing radiation for cervical cancer. Indian Journal of Medical Research.

2. Patel U, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB.(2022) Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab. British Journal of Cancer.

3. Patel KK, Chakravarti P, Chaturvedi P, Dikshit R, Budukh A. (2022) The fifth round of the National Family Health Survey of India 2019-2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast, and oral cancer. International Journal of Cancer.

4. Kaur E, Ketkar M, Dutt S.(2022) Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress. Medical Oncology. 39:50.

5. Mittal P, Chopra S, Charnalia M, Dora T, Engineer R, Mulani J, Scaria L, Prajapati K, Kannan S, Gurram L, Mahantshetty U, Gupta S, Shrivastava SK. (2022) Patterns of relapse after adjuvant (chemo) radiation for cervical cancer in a phase III clinical trial (PARCER): an evaluation of updated NRG Oncology /RTOG target delineation guidelines. International Journal of Radiation Oncology, Biology,Physics.

Site of the Week

DASHR (Database of small human non-coding RNAs) provides sharing and analysis services for data from life science researches and advances science.

desktop Image
Interesting Reads

Hayat U, Elliott GT, Olszanski AJ, Altieri DC. Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor. Cancer Biol Ther. 23(1):117-126, 2022.

Legends of Science
Srinivas Kishanrao Saidapur Srinivas Kishanrao Saidapur

S K Saidapur obtained his Ph.D. from the Karnataka University, Dharwad, in 1974. His research mainly focused on comparative endocrinology, the different types of reproductive processes, the tropical anurans, and their control mechanisms. His studies helped in understanding the reproductive biology of vertebrates. He developed new ways for the captive breeding of reptiles. Dr. Saidapur is elected Fellow of the Indian Academy of Sciences, Bangalore (1993); The National Academy of Sciences, Allahabad (2009); The World Academy of Sciences (2010). He is a recipient of the Shanti Swarup Bhatnagar Award (1991).

Subhash Chandra Lakhotia Subhash Chandra Lakhotia

Subhash Chandra Lakhotia received his doctorate from Kolkata University, Kolkata, in 1970. His research interests include cytogenetics, gene expression, cell, and developmental biology. His studies discovered how the IncRNA gene modulates apoptosis and neurodegeneration in Drosophila models of human diseases. Dr. Lakhotia was an elected fellow of INSA in 1993; the senior fellow of the Cell Stress Society International in 2017. He was awarded the prestigious Shanti Swarup Bhatnagar Award in 1989.

Upcoming Events
National Comprehensive Cancer Network (NCCN) Annual Conference 2022

31 March-2 April, 2022


Hereditary Gastric Cancer Symposium

04-05 April, 2022


Microbial infections and human cancer

6-9 April, 2022


Do You Know?

In 2001, Researcher first linked a specific gene, the E-Cadherin gene (CHD1) to a type of hereditary cancer.

back Image
Cancer News
Mapping mutation 'hotspots' in cancer reveals new drivers and biomarkers

09 February 2022, ScienceDaily

Researchers have identified a previously unrecognized key player in cancer evolution: clusters of mutations occurring at certain regions of the genome. These mutation clusters contribute to the progression of about 10 percent of human cancers and can be used to predict patient survival...

'Decision Switch' discovered in mutations linked to common brain tumor

09 February 2022, Eurekalert

In the new study, the research team showed that the most common extracellular mutations that occur in GBM prevent the EGFR from discriminating between the seven different growth factors that normally activate it...

Analysis of 2,658 tumors sheds new light on mutations in cancer

10 February 2022, MedicalXpress

The team examined 2,658 complete DNA sequences from 38 different types of tumors and found these double mutations in as many as 21% of cases...

� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)